Thirty-one-year survival following chemotherapy and autologous bone marrow in malignant lymphoma

5Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 21-year-old woman with malignant lymphoma received a large dose of nitrogen mustard followed by autologous bone marrow. She achieved a complete remission that lasted 21 years. This was followed in a span of 10 years by two relapses that responded to chemotherapy and splenectomy. Death resulted from sepsis. At autopsy, there was minimal evidence of malignant lymphoma, but evidence for side effects of chemotherapy was present.

Cite

CITATION STYLE

APA

Haurani, F. I. (1997). Thirty-one-year survival following chemotherapy and autologous bone marrow in malignant lymphoma. American Journal of Hematology, 55(1), 35–38. https://doi.org/10.1002/(SICI)1096-8652(199705)55:1<35::AID-AJH6>3.0.CO;2-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free